Results 1 to 10 of about 73,250 (305)

Epidemiology of idiopathic pulmonary fibrosis: a population registry-based study. [PDF]

Orphanet J Rare Dis
Francesca G, Michele S, Anna P, Paolo C, Davide C, Federico L, Francesco P, Elisabetta R, Laura T, Sara T, Carrozzi L, Elena B, Alessio C.   +12 more
europepmc   +1 more source

Spatial Distribution of K13-Positive Airway Epithelial Cells in Idiopathic Pulmonary Fibrosis. [PDF]

Biomedicines
Teng F, Zheng Q, Bai Y, Zhao Q, Fu Y, Dai H, Huang C, Ren T.   +7 more
europepmc   +1 more source

Cough Burden and Sleep Quality in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Therapy: A Cross-Sectional Study in Türkiye. [PDF]

J Clin Med
Kazci H, Tapan U, Oral Tapan O.
europepmc   +1 more source

Deep-learning networks accurately detect pulmonary hypertension in patients with idiopathic pulmonary fibrosis. [PDF]

ERJ Open Res
Arvanitaki A, Diller GP, Lawrence A, Mukherjee B, Semple T, Kouranos V, Li W, Gatzoulis MA, Price LC, Wort SJ.   +9 more
europepmc   +1 more source

Survival in familial idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis. [PDF]

Sarcoidosis Vasc Diffuse Lung Dis
Reis Estrella D, Mancuzo E, De Amorim Correa R, Tibana R, Soares MR, De Castro Pereira CA.   +5 more
europepmc   +1 more source

Shortened Telomere Length as a Risk Factor for Idiopathic Pulmonary Fibrosis: A Meta-Analysis. [PDF]

Open Respir Med J
Fachrucha F, Syuaib FI, Purwono A, Nurwidya F, Andarini SL, Burhan E, Wiyono WH.   +6 more
europepmc   +1 more source

Quantitative label-free multiphoton imaging of collagen features predicts disease severity and progression in idiopathic pulmonary fibrosis. [PDF]

Respir Res
Liu W, Sun Y, Zhao L, Wang S, Zhou G, Wang S, Xie S, Geng J, Xie B, Wang A, Dai H.   +10 more
europepmc   +1 more source

Monoallelic PARN mutation presenting as pancytopenia, hepatic fibrosis and idiopathic pulmonary fibrosis. [PDF]

BMJ Case Rep
Soni J, Sam KS, Taneja V, Khosla P.
europepmc   +1 more source

Targeting Lysyl Oxidase-like 2: A Therapeutic Strategy for Idiopathic Pulmonary Fibrosis with a Novel Indolizine Derivative. [PDF]

Pharmaceutics
Shim DH, Kim MJ, Chung HW, Kim MN, Sohn MH, Lee S, Kim I, Lee CG, Elias JA, Park JH, Lee JM.   +10 more
europepmc   +1 more source

Artificial intelligence in idiopathic pulmonary fibrosis: advances, challenges and future directions. [PDF]

Eur Respir J
Selman M, Buendia-Roldan I, Pardo A.
europepmc   +1 more source